230 related articles for article (PubMed ID: 32285140)
21. MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
Klassen LMB; Chequin A; Manica GCM; Biembengut IV; Toledo MB; Baura VA; de O Pedrosa F; Ramos EAS; Costa FF; de Souza EM; Klassen G
Gene; 2018 Feb; 642():461-466. PubMed ID: 29162512
[TBL] [Abstract][Full Text] [Related]
22. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
[TBL] [Abstract][Full Text] [Related]
23. Analysis of genes upregulated by the demethylating agent 5-aza-2'-deoxycytidine in gastric cancer cell lines.
Mikata R; Yokosuka O; Fukai K; Imazeki F; Arai M; Tada M; Kurihara T; Zhang K; Kanda T; Saisho H
Int J Cancer; 2006 Oct; 119(7):1616-22. PubMed ID: 16671088
[TBL] [Abstract][Full Text] [Related]
24. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
25. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas.
Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W
PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
27. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
Li T; Chen X; Gu M; Deng A; Qian C
Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
[TBL] [Abstract][Full Text] [Related]
28. Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
Zouridis H; Deng N; Ivanova T; Zhu Y; Wong B; Huang D; Wu YH; Wu Y; Tan IB; Liem N; Gopalakrishnan V; Luo Q; Wu J; Lee M; Yong WP; Goh LK; Teh BT; Rozen S; Tan P
Sci Transl Med; 2012 Oct; 4(156):156ra140. PubMed ID: 23076357
[TBL] [Abstract][Full Text] [Related]
29. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer.
Wang JF; Dai DQ
World J Gastroenterol; 2007 Nov; 13(43):5692-8. PubMed ID: 17963294
[TBL] [Abstract][Full Text] [Related]
30. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.
Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D
Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
Zhang C; Zou Y; Dai DQ
Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
[TBL] [Abstract][Full Text] [Related]
34. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.
Wang P; Wang YC; Chen XY; Shen ZY; Cao H; Zhang YJ; Yu J; Zhu JD; Lu YY; Fang JY
Cancer Sci; 2012 Jul; 103(7):1327-33. PubMed ID: 22590977
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.
Ghadami E; Nikbakhsh N; Fattahi S; Kosari-Monfared M; Ranaee M; Taheri H; Amjadi-Moheb F; Godazandeh G; Shafaei S; Nosrati A; Pilehchian Langroudi M; Samadani AA; Amirbozorgi G; Mirnia V; Akhavan-Niaki H
J Cell Physiol; 2019 Apr; 234(4):4115-4124. PubMed ID: 30132887
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
37. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
38. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway.
Liu D; Liu Y; Zhu W; Lu Y; Zhu J; Ma X; Xing Y; Yuan M; Ning B; Wang Y; Jia Y
BMC Med; 2023 Apr; 21(1):134. PubMed ID: 37016382
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
